Adverse effects have limited the clinical use of telithromycin. Preferential inhibition of the nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction (alpha 3 beta 2 and NMJ), the ciliary ganglion of the eye (alpha 3 beta 4 and alpha 7), and the vagus nerve innervating the liver (alpha 7) could account for the exacerbation of myasthenia gravis, the visual disturbance, and the liver failure seen with telithromycin use. The studies presented here enable the prediction of expected side effects of macrolides in development, such as solithromycin (CEM-101).
机构:
Pfizer Global R&D, Drug Safety Res & Dev, Dept Investigat Toxicol, Groton, CT 06340 USAPfizer Global R&D, Drug Safety Res & Dev, Dept Investigat Toxicol, Groton, CT 06340 USA
Liu, Chang-Ning
Somps, Chris J.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Global R&D, Drug Safety Res & Dev, Dept Investigat Toxicol, Groton, CT 06340 USAPfizer Global R&D, Drug Safety Res & Dev, Dept Investigat Toxicol, Groton, CT 06340 USA
机构:
Pfizer Global R&D, Drug Safety Res & Dev, Dept Investigat Toxicol, Groton, CT 06340 USAPfizer Global R&D, Drug Safety Res & Dev, Dept Investigat Toxicol, Groton, CT 06340 USA
Liu, Chang-Ning
Somps, Chris J.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Global R&D, Drug Safety Res & Dev, Dept Investigat Toxicol, Groton, CT 06340 USAPfizer Global R&D, Drug Safety Res & Dev, Dept Investigat Toxicol, Groton, CT 06340 USA